Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Filtration Microplates

By Drug Discovery Trends Editor | July 17, 2012

The need for reliable methods to purify samples and improve assays has led Porvair Sciences to develop a range of multi-well filtration microplates optimized for applications including cell harvesting, DNA separations, binding studies, plasmid isolation, general filtration and sample clean-up.

Filtration plates are used in their simplest form to remove particulate matter from liquid, typically either the particulate matter or the filtrate is needed for further study.

Included within the Porvair range are filtration plates that can simultaneously filter 96 or 384 samples of up to 350µL volume providing great productivity benefits and high filtered sample integrity. For larger volume applications (up to 5 mL/well) a choice of 48-well filtration plates are available. A broad range of filtration media including glass fibre, nylon, PVDF and polyethylene allows control of filtration plate flow rates and retention characteristics to best suit your application. Manufactured to the standard ANSI/SBS footprint all Porvair Filtration plates are fully automation compatible.

Each well on Porvair filtration plates has an individual drainage spout ensuring 100% sample transfer and zero crossover contamination. Manufactured from ultra pure grade polypropylene – all Porvair filtration plates minimise leachates when used with most common solvents ensuring the highest filtered sample integrity.

Porvair Sciences


Filed Under: Drug Discovery

 

Related Articles Read More >

Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE